L13.0
Dermatitis herpetiformis
Clinical Classification Guidelines
Inclusion Terms
- Duhring's disease
- Hydroa herpetiformis
Excludes Type 1
- juvenile dermatitis herpetiformis (L12.2)
- senile dermatitis herpetiformis (L12.0)
Medical Intelligence & Overview
Dermatitis herpetiformis, also known as Duhring's disease, is a chronic skin condition characterized by intensely itchy and blistering skin eruptions. It is considered a manifestation of gluten intolerance and is closely linked with celiac disease. This condition typically presents as clusters of small, blistering bumps on the skin, often on areas such as elbows, knees, back, and buttocks. Recognizing the symptoms and understanding the causes are essential for proper management and treatment.
Causes & Symptoms
Clinical Causes: Gluten sensitivity: An autoimmune response triggered by the ingestion of gluten found in wheat, barley, and rye. Genetic predisposition: Certain genes related to immune function increase susceptibility. Immune system response: The immune system mistakenly attacks skin components in response to gluten exposure, leading to blister formation.
Key Symptoms: Intensely itchy skin rash Clusters of small, blistering bumps or vesicles Rashes often appear symmetrically on elbows, knees, scalp, back, and buttocks Skin lesions may heal with hyperpigmentation or hypo-pigmentation In some cases, skin may be covered with crusts or scales Possible associated symptoms of celiac disease include abdominal pain, diarrhea, and weight loss
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination, skin biopsy, and blood tests. A skin biopsy from a lesion can show characteristic deposits of immunoglobulin A (IgA) in the dermal papillae. Blood tests measuring anti-tissue transglutaminase (tTG) antibodies may support the diagnosis. It's also common for healthcare providers to recommend a gluten-free diet trial to observe symptom improvement.
Treatment Protocols: Management primarily focuses on gluten avoidance, which can lead to significant symptom improvement. Pharmacologic treatments may include medications such as dapsone, which effectively reduces skin symptoms but may have side effects requiring monitoring. Strict adherence to a gluten-free diet is essential to prevent symptoms and reduce the risk of associated complications like intestinal damage from celiac disease. Regular follow-up with healthcare professionals and ongoing monitoring of antibody levels are recommended.
Clinical Advice & FAQs
Billing Guidance
Is L13.0 a billable ICD-10 code?
Yes, L13.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L13.0?
Clinical documentation must specify the nature of Dermatitis herpetiformis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
